New Blood Test Could Bring Early Alzheimer Disease Detection to More People
A novel blood test offers affordable early detection of Alzheimer disease, enhancing awareness and intervention opportunities during Alzheimer’s and Brain Awareness Month.
Related Articles
Atherosclerosis in Patients with SLE & the Risk of Progression: A 10-Year View – The Rheumatologist
Research from Papazoglou et al. highlights the substantial risk of atherosclerosis progression and incident cardiovascular events in patients with systemic lupus erythematosus, as well as…
ACP Advocate | ACP Online
The ACP Advocate is a bi-weekly e-newsletter that provides ACP members with news about public policy issues affecting internal medicine.
Revumenib Shows Efficacy in Patients With AML and Genetic Alterations
Revumenib shows promise for high-risk patients with acute myeloid leukemia (AML) with specific genetic mutations, demonstrating efficacy with no new safety signals.
Safety of Acamprosate in Patients With Alcohol-Associated Liver Disease: A Single-Arm Phase 2 Trial
To investigate the safety of acamprosate, a Food and Drug Administration–approved medication for alcohol use disorder, in patients with alcohol-associated liver disease.
Does Medical School Prestige Impact Match Rates in Competitive Specialties? A Retrospective Analysis
Matching into a competitive specialty has historically required extensive research, leadership, and extracurricular activities. Since the United States Medical Licensing Examination (USMLE) Step…
Evaluating Access to Care for Medicare Beneficiaries Younger Than 65 Years
Enrollment in Medicare coverage without out-of-pocket protections was associated with a higher likelihood of reporting cost and access barriers to care.
Biophysics | bioRxiv
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
Genomics | bioRxiv
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
Pharmacology and Toxicology | bioRxiv
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
ADVANCE Trial Supports DKRd as New Standard of Care for Newly Diagnosed Multiple Myeloma: Ola Landgren, MD, PhD
Ola Landgren, MD, PhD, shares ADVANCE trial results, which show that adding daratumumab to carfilzomib-lenalidomide-dexamethasone (DKRd) improves outcomes in newly diagnosed multiple myeloma.